
ABIGO Medical AB
Sorbact
Select market
Africa
BotswanaEgyptGhanaKenyaLesothoMauritaniaMauritiusMoroccoMozambiqueNamibiaNigeriaSeychellesSouth AfricaSudanSwazilandTanzaniaUgandaZambiaAsia-Pacific
AustraliaBahrainChinaHong KongIndiaIndonesiaIraqJapanJordanKuwaitMacaoNew ZealandOmanPakistanPhilippinesQatarSingaporeSouth KoreaSouth of PalestineThe Kingdom of Saudi ArabiaUnited Arab EmiratesYemen
Evidence
Proven to prevent and treat wound infection
Proven in more than 40 clinical studies and in publications including over 7,000 patients, Sorbact® has more than 30 years of successful use in clinical practice. Today Sorbact® is helping patients in over 65 countries around the world and we are continuing this important work by collecting clinical data.